Plain-English translation of NCT07115563 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a targeted amino acid supplement—a blend of specific amino acids (leucine, tryptophan, arginine, taurine, glutamate, and tyrosine)—designed to address nutritional deficiencies common in people with Parkinson's disease. Researchers want to see whether taking this medication daily can improve your body's amino acid levels, metabolism, muscle and body composition, physical ability, and overall quality of life. Half of participants will receive the specialized blend, and half will receive a control supplement, so researchers can compare the results.
People with Parkinson's disease often have imbalances in their amino acid levels, which may affect muscle strength, movement, and overall health. This trial exists to find out whether this treatment can safely correct those imbalances and help people manage their symptoms better.
You likely qualify if…
You likely don't qualify if…
You will take a daily amino acid supplement (either the specialized blend or a control) as part of your regular routine. The study will involve blood draws to measure your amino acid levels and assess metabolic health, as well as tests of your physical function and questionnaires about how you're feeling. The exact number and timing of visits will be explained when you enroll, but the researchers will work with you to make participation manageable alongside your regular Parkinson's care.
AI-generated summary from trial data · Aug 16, 2026 · Not medical advice
United States